Thomas A. Lindheimer – Trademark Portfolio

Entity Type: 01

Thomas A. Lindheimer holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RXBIDET and PERI-JETT PERINEAL RINSE AID. The owner is based in Lewisville, NC.

4800 Williams Road

Lewisville, NC 27023

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Thomas A. Lindheimer's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does Thomas A. Lindheimer have?

Thomas A. Lindheimer has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Thomas A. Lindheimer file in?

Thomas A. Lindheimer files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Thomas A. Lindheimer's most well-known trademarks?

Thomas A. Lindheimer's registered trademark portfolio includes well-known marks such as RXBIDET and PERI-JETT PERINEAL RINSE AID. These are among 2 currently registered trademarks in the portfolio.

What is Thomas A. Lindheimer's trademark registration success rate?

Thomas A. Lindheimer has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.